propargylglycine has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, J; Li, X; Lu, R; Shi, H; Sun, K; Xu, W; Ye, F; Ye, Y | 1 |
| Kawabata, A; Ogura, A; Sekiguchi, F; Sekimoto, T | 1 |
2 other study(ies) available for propargylglycine and Stomach Neoplasms
| Article | Year |
|---|---|
Inhibition of endogenous hydrogen sulfide biosynthesis enhances the anti-cancer effect of 3,3'-diindolylmethane in human gastric cancer cells.
Topics: Alkynes; Aminooxyacetic Acid; Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Drug Synergism; Glycine; Humans; Hydrogen Sulfide; Indoles; p38 Mitogen-Activated Protein Kinases; Stomach Neoplasms; Tumor Suppressor Protein p53 | 2020 |
Endogenous Hydrogen Sulfide Enhances Cell Proliferation of Human Gastric Cancer AGS Cells.
Topics: Alanine; Alkynes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cystathionine gamma-Lyase; Glycine; Humans; Hydrogen Sulfide; L-Lactate Dehydrogenase; Stomach Neoplasms; Sulfides | 2016 |